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Abstract
The pathophysiological hallmark of spotted fever group rickettsioses comprises vascular inflammation. Based on the
emerging importance of the wingless (Wnt) pathways in inflammation and vascular biology, we hypothesized that
Dickkopf-1 (DKK-1), as a major modulator of Wnt signaling, could be involved in the pathogenesis in rickettsial infections.
Our major findings were: (i) While baseline concentration of DKK-1 in patients with R. conorii infection (n = 32) were not
different from levels in controls (n = 24), DKK-1 rose significantly from presentation to first follow-up sample (median 7 days
after baseline). (ii) In vitro experiments in human umbilical vein endothelial cells (HUVECs) showed that while heat-
inactivated R. conorii enhanced the release of interleukin-6 (IL-6) and IL-8, it down-regulated the release of endothelial-
derived DKK-1 in a time- and dose-dependent manner. (iii) Silencing of DKK-1 attenuated the release of IL-6, IL-8 and
growth-related oncogene (GRO)a in R. conorii-exposed HUVECs, suggesting inflammatory effects of DKK-1. (iv) Silencing of
DKK-1 attenuated the expression of tissue factor and enhanced the expression of thrombomodulin in R. conorii-exposed
HUVECs suggesting pro-thrombotic effects of DKK-1. The capacity of R. conorii to down-regulate endothelial-derived DKK-1
and the ability of silencing DKK-1 to attenuate R. conorii-induced inflammation in endothelial cells could potentially reflect a
novel mechanism by which R. conorii escapes the immune response at the site of infection.
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Introduction
Rickettsiae are Gram-negative intracellular bacteria transmitted
by arthropod vectors. Rickettsioses can present clinically in an
array of different clinical symptoms; the most consistent being
fever, myalgia, lymphadenopathy, and headache, with or without
eschar and/or maculopapular eruption [1]. The clinical spectrum
of spotted fever group (SFG) rickettsioses varies in severity from
mild to potentially lethal disease with systemic multi-organ
involvement such as in some cases of Rocky Mountain spotted
fever (RMSF) caused by Rickettsia rickettsii (R. rickettsii) and
Mediterranean spotted fever (MSF) caused by R. conorii [1].
The pathophysiological hallmark of SFG rickettsioses comprises
infection of endothelial cells and subsequent perivascular infiltra-
tion of T cells and monocytes/macrophages, resulting in vasculitis,
with increased microvascular permeability and in some cases,
cerebral and pulmonary edema [1,2]. This interaction between
microbe and endothelial cells triggers innate immune responses,
including the production of several cytokines by endothelial and
non-endothelial cells, representing both beneficial (i.e., anti-
microbial) and detrimental (e.g., tissue destruction and excessive
inflammation) responses in relation to the infected host [1,2].
Immune escape or immune evasion is an important mechanism
for microbe survival within the host to avoid innate and adaptive
immune responses. Such mechanisms are of importance in viral,
bacterial and parasitic infection, and are thought to be of
particular relevance for intracellular bacterial infection [3]. The
immune evasion mechanisms for bacteria involve molecular
mimicry, suppression of antibodies, hiding inside cells and
inhibition of phagocytosis [3]. There are also some reports
suggesting that such mechanisms could be operating in Rickettsial
infection [2,4], but these issues are far from clear.
The wingless (Wnt) pathway involves a large number of proteins
that participate in a range of developmental and physiological
processes including cardiac and vascular development. Wnt
signaling is regulated by multiple families of secreted antagonists
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such as soluble frizzled related receptors and dickkopfs (DKKs).
The best studied of these is DKK-1, which dampens the Wnt
signal by binding to the LPR5/6 receptor and a cell surface co-
receptor, Kremen-1/2, promoting internalization of the receptor
complex [5]. In adults, DKK-1 has been implicated in the
pathogenesis of bone disease, cancer, Alzheimer’s disease, and
brain ischemia [5,6]. Recent studies also point to an important
role of the Wnt signaling pathways and DKK-1 in the regulation
of inflammation. Thus, activation of the canonical Wnt/b-catenin
pathway induces proliferation and survival of endothelial cells,
enhances monocyte adhesion, and regulates transendothelial
migration of monocytes [7–10]. Also, the destructive effect of
tumor necrosis factor a (TNFa) on joints in rheumatoid arthritis
was found to involve DKK-1 [6], and we have shown that platelet-
and endothelial-derived DKK-1 could contribute to vascular
inflammation in atherosclerosis [11]. The Wnt signaling pathway
has recently also been implicated in the pathogenesis of certain
infectious disorders including septicemia [12] and infection by
intracellular pathogens (i.e., Chlamydia infection) [13].
Based on the emerging importance of the Wnt signaling
pathways in inflammation and vascular biology, we hypothesized
that DKK-1, as a major modulator of Wnt signaling, could be
involved in the pathogenesis of rickettsial infections. Here, this
hypothesis was investigated by various experimental approaches
including in vivo studies in patients with R. conorii infection as well as
in vitro studies focusing on the role of DKK-1 in the interaction
between R. conorii and endothelial cells using heat-inactivated R.
conorii as a model for the early phase of this interaction.
Methods
Patients and controls
Thirty-two consecutively recruited patients (17 women and 15
men, 19–90 [mean 61.5] years of age) with MSF, confirmed by
seroconversion, admitted to the Termini Imerese Hospital
Palermo, Palermo, Italy, between June and September 2005,
were included in the study [14]. They all had characteristic signs
and symptoms of active MSF (fever, eschar at the site of tick bite,
and maculopapular rash). The duration of illness before diagnosis
was less than 2 weeks. One patient received cephalosporin, two
ciprofloxacin, one received no treatment, whereas the remaining
patients were treated with tetracycline (500 mg 4 times a day for 7
days). All patients with MSF had seroconversion with increases in
the levels of anti-R. conorii antibodies as assessed by enzyme-linked
immunosorbent assay (ELISA) and indirect immunofluorescence
assay [15]. Twenty-four healthy subjects (9 women and 15 men,
aged 21–67 [mean 43.4] years), recruited from the same area of
Italy, were included in the study as controls. All controls were
healthy individuals as assessed by disease history, clinical
examination and normal C-reactive protein levels, with no signs
of concomitant disease that could interfere with DKK-1 levels. All
patients were invited to sign the medical records and received
information and consented that their blood sampling might be
used for future investigations regarding their disease.
All parts of the study were approved by the local ethical
committee and conducted according to the ethical guidelines from
the declaration of Helsinki (Ref IRB, Termini Imerese Hospital
Palermo, Palermo, Italy and Regional Committee for Medical and
Research Ethics, South-East, Norway, ref 248-08/239 2008/230).
Blood sampling protocol
Blood was collected both at first presentation (less than 2 weeks
after the onset of the symptoms and before specific treatment), and
at two times during follow-up (median 7 days and .21 days after
baseline samples). At the last blood sampling, all patients had
recovered and were free of clinical symptoms. Peripheral venous
blood was drawn into pyrogen-free, vacuum blood collection tubes
without any additives, immediately immersed in melting ice and
allowed to clot before centrifugation at 2000g for 10 minutes.
Serum was stored at 280uC until analysis and samples were
thawed less than three times.
Bacteria
R. conorii (Malish strain) were grown in Vero cell monolayers in
150 cm2 tissue culture flasks, cultured in Modified Eagle Medium
(MEM; Gibco, Paisley, UK), supplemented with 4% fetal calf
serum (FCS) and 2 mM L-glutamine. Heavily infected cells (5 days
post-inoculation) were harvested with sterile glass beads and
pelleted by centrifugation at 10,000g for 15 minutes. Antigens used
were purified by sucrose gradients and were entire bacterial
antigens. The pellets were resuspended in sterile distilled water so
that each suspension had the same density of organisms as
determined microscopically at6100 magnification [16]. Different
dilutions of this suspension were used for in vitro experiments. The
batch contained 10 million rickettsiae/ml and was diluted in
phosphate buffered saline (PBS) before being added to the cell
cultures. Heat-inactivated organisms were obtained by heating at
60uC for 30 minutes. All experiments with live bacteria were
conducted under Biosafety Level 3 (BSL3) conditions.
Endothelial cell culture
Human umbilical vein endothelial cells (HUVECs) were
obtained from umbilical cord veins by digestion with 0.1%
collagenase A (Roche Diagnostics GmbH, Mannheim, Germany)
and cultured as previously described [17]. HUVECs were
passaged by treatment with 0.05% trypsin-EDTA (Gibco) and
grown to confluence for 3 to 5 days. The HUVECs were used at
passage levels 4–9. The medium was then discarded, and
HUVECs were stimulated with different concentrations of heat-
inactivated R. conorii in MCDB-131 serumfree medium (Sigma St.
Louis MO), except for the long-term stimulations (up to 120 hrs),
when it was supplemented with 50% fetal bovine serum (Gibco).
In a separate set of experiments, HUVECs were transfected with
small interfering RNA (siRNA) against DKK-1 prior to exposure
to heat-inactivated R. conorii (see below). Cell-free supernatants and
cell pellets were harvested after various time points and stored at
280uC until analyses. The density of the endothelial cells were
,86.000 cells per well, and as an example, 46105 bacteria per ml
will give approximately 1.4 bacteria/cell. The toxicity in cell
cultures was examined for lactate dehydrogenase leakage using a
cytotoxicity detection kit (Roche Applied Science, Indianapolis,
IN).
Cultures of THP-1 macrophages and vascular smooth
muscle cells (SMC)
In a separate set of experiments, Tamm-Horsfall protein 1
(THP-1) macrophages and vascular SMC were incubated with
heat-inactivated R. conorii. The human monocytic cell line THP-1
(American Type Culture Collection, Rockville, MD) was cultured
in RPMI 1640 (PAA laboratories, Pasching, Austria), supplement-
ed with 2.5% fetal bovine serum. Before the experimental start,
the THP-1 cells were differentiated into macrophages by
incubation for 24 hours with phorbol myristate acetate (PMA,
100 nM; Sigma) before resting for additional 48 hours, and
further incubated with or without heat-inactivated R. conorii.
Human aortic SMC were obtained from PromoCell GmbH
(Heidelberg, Germany) and grown in SMC Growth Medium 2
DKK-1 in Rickettsia conorii Infection
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with complete supplement mix (PromoCell). At 90% confluence,
the culture was trypsinized and replated. At experimental start, the
cells were cultured in Optimem with Glutamax (Gibco-Invitrogen,
Carlsbad, CA) with or without heat-inactivated R. conorii. At
different time points, cell-free supernatants were harvested and
stored at 280uC.
Preparation and stimulation of platelets
Preparation and stimulation of platelets were performed as
previously described [18]. Briefly, one-fourth volume of acid-
citrate-dextrose (85 mM trisodium citrate, 71.4 mM citric acid
and 111 mM glucose, pH=4.5) was added to platelet-rich plasma
prior to centrifugation at 1,500g for 7 minutes at 22uC. The
platelets were then resuspended in MCDB-131 media (56108
platelets/ml) before stimulation with R. conorii for 1 hour. DKK-1
levels were determined in platelet-free solution (centrifugation of
platelet suspension for 5 minutes at 10,000g) at the end of the
experiment.
Whole blood experiments
Human whole blood from four different healthy donors was
collected. The blood was anti-coagulated with lepirudin (50 mg/
ml), and immediately split into sterile polypropylene tubes (1.8 ml
NUNC cryotubes) for incubation. The blood was incubated under
tilting for 4 hours at 37uC with and without heat-inactivated R.
conorii diluted in PBS with CaCl2 and MgCl2 (Sigma). Further
activation was blocked by adding EDTA (10 mM). The tubes were
centrifuged for 15 minutes at 4000g at 4uC. Plasma was stored at
280uC until being analyzed for DKK-1-release.
Preparation and transfection of siRNA
siRNAs with the following sense and antisense sequences were
used: DKK-1, first strand (sense), 59-GCUUCACACUUGUCA-
GAGAtt-39, second strand (antisense), 59-UCUCUGACAAGU-
GUGAAGCct-39. Scrambled control, a non-targeting siRNA
(siSCR), was used as control. All sequences were provided from
Applied Biosystems (Foster City, CA). For transfection, 50 nM
siRNA duplexes and 6 ml HiPerFect transfection reagent (Qiagen,
Hilden, Germany) were prepared in OptiMem with glutamax-1
(Gibco-Invitrogen, Carlsbad, CA), and added when HUVECs
reached 70% confluence at a final volume of 300 ml in 12-well
plates (Costar, Cambridge, MA). The concentration of siRNA
duplexes (50 nM) was based on dose-response efficacy experiments
and toxicity studies (lactate dehydrogenase [LDH] release), and
importantly, there was no difference in LDH-release between
siDKK-1 and siSCR exposed HUVECs. After 6 hours, 300 ml
medium with 10% FCS was added to the cells for overnight
incubation. After 24 hours incubation, the cells were cultured with
or without R. conorii as described above. In a separate experiment,
the transfected cells were incubated with or without different
concentration of recombinant DKK-1 (R&D Systems, Minneap-
olis, MN).
Isolation of nuclear and cytoplasmic extract of HUVECs
The cells were seeded in 12 well plates and grown to confluence.
They were treated for 15 and 120 min with vehicle and R. conorii,
(n = 4), and washed twice with cold PBS. Thereafter cells were
scraped and resuspended in cell lysis buffer (10 mM Tris-HCl
pH 7.4, 10 mM NaCl, 3 mM MgCl, protease inhibitor cocktail
tablet [EDTA-free; Roche, Basel, Switzerland], 1 mM phenyl-
methylsulfonyl fluoride, 0.3% Igepal) on ice, and centrifuged at
5000g for 6 minutes at 4uC. The supernatant fraction (cytoplasmic
extract) was removed, centrifuged again at 5000g for 6 minutes at
4uC and supernatants were stored at 80uC until further analyses.
The cell pellet (nuclear fraction) was washed twice in cell lysis
buffer, (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl,
protease inhibitor cocktail tablet [EDTA-free; Roche, Basel,
Switzerland], 1 mM phenylmethylsulfonyl fluoride) on ice, and
resuspended in another cell lysis buffer (50 mM Hepes pH 7.5,
125 mM NaCl, 0.5% Igepal, 1 mM EDTA, 5% glycerol, 1 mM
NaF, protease inhibitor cocktail tablet [EDTA-free; Roche],
1 mM phenylmethylsulfonyl fluoride), briefly sonicated (approx.
2 sec), centrifuged at 5000g for 6 minutes at 4uC and supernatants
were stored at 80uC until further analyses.
Intracellular total b-catenin measurements
Both phosphorylated and unphosporylated b-catenin was
measured by ELISA from R&D Systems in nuclear and
cytoplasmic cell fractions and correlated to total protein (BCA
Protein Assay Kit; Pierce, Rockford, IL).
Real-time quantitative RT-PCR
Total RNA was extracted from HUVECs using RNeasy
columns (Qiagen), subjected to DNase I treatment, and stored in
RNA storage solution (Ambion, Austin, TX) at 280uC. Primers
for DKK-1 (forward primer [FP]: 59-GGGAATTACTG-
CAAAAATGGAATA-39 and reverse primer [RP]: 59-AT-
GACCGGAGACAAACAGAAC-39), interleukin-6 (IL-6) (FP: 59-
AGCCCTGAGAAAGGAGACATGTA-39 and RP: 59-
CATCTTTGGAAGGTTCAGGTTGT-39), monocyte chemoat-
tractant protein 1 (MCP-1) (FP: 59-AAGCTGTGATCTTCAA-
GACCATTGT-39 and RP: 59-TGGAATCCTGAACC-
CACTTCTG-39), growth-related oncogene (FP: 59-
TGCGCCCAAACCGAAG-39 and RP: 59-TGCAGGATT-
GAGGCAAGCTT-39), IL-8 (FP: 59-GCCAACACAGAAAT-
TATTGTAAAGCTT-39 and RP: 59-CCTCTGCACC-
CAGTTTTCCTT-39), plasminogen activator inhibitor (PAI)-1
(FP: 59-AGGCTGACTTCACGAGTCTTTCA-39 and RP: 59-
GCTGAGACTATGACAGCTGTGGAT-39), tissue factor (TF)
(FP: 59-GCGCTTGAGGCACTAAAAT-39 and RP: 59-
TTTGCTTTTCCAATCTCCTGA-39), and thrombomodulin
(FP: 59-CCCAACACCCAGGCTAGCT-39 and RP: 59-
CGTCGATGTCCGTGCAGAT-39) were designed using the
Primer Express software, version 2.0 (Applied Biosystems).
Quantification of mRNA was performed using the ABI Prism
7500 (Applied Biosystems). Gene expression of the housekeeping
gene b-actin (Applied Biosystems) was used for normalization.
ELISA
Levels of IL-6, IL-8, MCP-1, GROa, and DKK-1 were
measured by ELISAs obtained from R&D Systems. The intra-
and inter-assay coefficients of variations were ,10% for all
ELISAs. To further minimize run-to-run variability, serial samples
from a given individual were analyzed on the same tray.
Statistical methods
In vivo data (i.e. serum) were analyzed by non-parametric
statistics: Mann-Whitney U test for comparing patients and
controls and Wilcoxon signed-rank test for comparing changes
in individuals over time. In addition, linear regression was used to
verify differences in DKK-1 levels due to differences in age
between patients and controls (i.,e., log transformed DKK-1 levels
as dependent variable and age and group as independent in a
forced linear regression). For in vitro data, parametric statistics were
used. When two groups were compared (i.e. siRNA experiments
comparing the same time point or R. conorii concentration between
DKK-1 in Rickettsia conorii Infection
PLOS ONE | www.plosone.org 3 September 2012 | Volume 7 | Issue 9 | e43638
siSCR and siDKK-1), unpaired t-tests were used, while in some
dose experiments with 3 or more groups to compare (i.e. un-
stimulated and 2 or 3 doses), a one way ANOVA was used first
and if significant, unpaired t-test was used to compare differences
with the un-stimulated situation. The level of significance was set
at p,0.05.
Results
Serum levels of DKK-1 in MSF patients
While baseline (less than 2 weeks after the onset of the
symptoms and before specific treatment) concentrations of DKK-1
in patients with MSF (n= 32) were not different from levels in
healthy controls (n = 24), DKK-1 rose significantly from presen-
tation to first follow-up sample (median 7 days after baseline),
reaching levels that were 2-fold higher than in healthy individuals
(Figure 1). This late surge is in contrast to the immediate increase
in levels of established inflammatory parameters such as IL-8 and
circulating adhesion molecules that are seen during R. conorii
infection [14]. After recovery (.21 days after baseline), DKK-1
decreased to reach the same levels as on first presentation
(Figure 1).
The control group was somewhat younger than the MSF
patients (see Methods), but we found no significant or non-
significant trend for the association between age and DKK-1 levels
in neither patients nor controls (data not shown). However, as
there was a significant difference in age between patients and
controls, we wanted to make it clear that the differences in DKK-
1-levels were not due to age differences and importantly, a
significant difference (p = 0.003) in DKK-1 levels at time point 2
(first follow-up sample) between patients and controls was observed
also when adjusting for age using linear regression. Blood samples
from the control group were only collected at one time point.
However, when collecting serum samples longitudinally (baseline,
1 week and 3 weeks) from 9 additional healthy controls to evaluate
the stability of DKK-1 levels over time, the coefficient of variation
for DKK-1 levels was 16.7612.6%. Although this reflects some
variation, it is clearly below the increase in DKK-1 levels from
baseline to time point 2 in MSF patients (Figure 1).
Effects of heat-inactivated R. conorii in endothelial cells
We have previously shown that endothelial cells release large
amounts of DKK-1 upon activation [11], and these cells are also
clearly relevant in relation to rickettsial infection. We therefore
next examined the ability of heat-inactivated R. conorii to modulate
DKK-1 release in HUVECs. As shown in Figure 2, R. conorii
promoted a significant decrease in the release of DKK-1 from
HUVECs in a dose- and time-dependent manner, with a maximal
suppression after 120 hours at a concentration of 105/ml. In
contrast to this suppressive effect on DDK-1 release, R. conorii
enhanced the release of the prototypical inflammatory cytokines
IL-8 and IL-6, emphasizing that R. conorii may differentially
regulate DKK-1 and inflammatory cytokines (i.e., IL-8 and IL-6)
in HUVECs (Figure 2). The culture media was not changed
during the culture period (120 hours), and the increase in IL-6 and
IL-8 levels over time most probably reflects accumulation of these
proteins in combination with enhanced synthesis.
Effects of heat-inactivated R. conorii on DKK-1 release in
other cells with relevance to MSF
Platelets have been shown to release significant amounts of
DKK-1 upon activation [11], and we have previously shown that
heat-inactivated R. Africae could promote platelet action [19]. To
Figure 1. Serum levels of DKK-1 in patients with MSF. The figure
shows serum DKK-1-levels measured at baseline (BL), first follow-up (T1,
median 7 days after baseline) and after recovery (T2, .21 days after
baseline) in 32 patients with MSF and in 24 healthy controls (grey area
represent mean695% CI of healthy controls). Data are given as
mean6SEM. {P,.001 vs. baseline, *P,.001 vs. controls.
doi:10.1371/journal.pone.0043638.g001
Figure 2. The effect of R. conorii on cytokine in release in
HUVECs. The figure shows the effect of different concentrations of
heat-inactivated R. conorii on the release of IL-8 (left panels), IL-6
(middle panels) and DKK-1 (right panels) in HUVECs after culturing
for 5 (A), 24 (B), 48 (C) and 120 (D) hours. Data are given as mean6SEM
(n = 6). *P,.05, **P,.01 and ***P,.001 vs. un-stimulated cells (US).
doi:10.1371/journal.pone.0043638.g002
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examine wether platelets and other cells with relevance to R. conorii
infection could contribute to serum levels of DKK-1 during MSF,
we examined the ability of heat-inactivated R. conorii to modulate
the release of DKK-1 in vascular SMC, macrophages, whole
blood cultures and platelets. As in endothelial cells, R. conorii down-
regulated DKK-1 release in vascular SMC, but the levels were in
general markedly lower than in endothelial cells (Figure 3). In
contrast, heat-inactivated R. conorii enhanced the release of DKK-1
from washed platelets and whole blood with the same pattern in
these two cell cultures, potentially reflecting effects on platelets in
the whole blood culture (Figure 3). Finally, R. conorii had no effect
on the release of DKK-1 in THP-1 macrophages (Figure 3).
Heat-inactivated R. conorii activates the Wnt pathway in
endothelial cells
To examine if endothelial-derived DKK-1 could modulate the
interactions between R. conorii and endothelial cells, we first
examined if heat-inactivated R. conorii could activate the Wnt
pathway in these cells. The canonical Wnt/b-catenin pathway
stimulates stabilization and accumulation of cytosolic, and then
later nuclear b-catenin, which binds to sensitive transcription
factors [20]. As shown in Figure 4, heat-inactivated R. conorii
induced accumulation of b-catenin within the nucleus after
2 hours, suggesting that R. conorii promotes activation of canonical
Wnt/b-catenin pathway in HUVECs.
Effect of silencing DKK-1 on the R. conorii-mediated
induction of inflammatory cytokines in endothelial cells
In order to further examine the interaction between R. conorii
and the Wnt pathway, we transfected HUVECs with siRNA
probes to silence DKK-1. HUVEC spontaneously expressed large
amounts of DKK-1 at both mRNA and protein levels, and we
found successful silencing of DKK-1 as assessed by real-time RT-
PCR (,48%) and by ELISA (,78%) 48 hours post-transfection
(Figure 5). Heat-inactivated R. conorii induced a significant increase
in IL-6, IL-8 and GROa levels compared with un-stimulated cells,
although the increase in GROa was only seen at the mRNA level
(Figure 5). Notably, silencing DKK-1 attenuated the R. conorii-
mediated release of these inflammatory cytokines (Figure 5). This
effect was particularly marked for IL-6, but did not reach statistical
significance for IL-8 (p= 0,19) (Figure 5). The cells were cultured
with heat-inactivated R. conorii for 24 hours following the initial
24 hours of transfection. The same patterns were also seen at the
mRNA levels (6 hours), suggesting that DKK-1 influences the
production and not only the release of these inflammatory
mediators (Figure 5). Silencing DKK-1 markedly down-regulated
the inflammatory response upon exposure to heat-inactivated R.
conorii. Still, the R. conorii-induced IL-6 and IL-8 response at the
protein level, but not the GROa response that was even lower
than in un-stimulated cells, was significantly increased as
compared to the un-stimulated condition in non-silenced cells
(Figure 5). In contrast to the effect on IL-6, IL-8 and GROa,
silencing DKK-1 did not modulate the R. conorii-induced
expression of MCP-1 neither at protein nor mRNA levels (data
not shown).
Figure 3. The effect of R. conorii on DKK-1 release in various
cells and cell lines. The figure shows the effect of heat-inactivated R.
conorii (105/ml A–C, 104/ml D) on the release of DKK-1 in cell free
supernatants in vascular SMC (A, culture time 20 hours), THP-1
macrophages (B, culture time 20 hours), washed platelets (C, culture
time 1 hour) and whole blood (D, culture time 4 hours). Data are given
as mean6SEM (n = 4–6). *P,.05 and ***P,.001 vs. un-stimulated cells
(US).
doi:10.1371/journal.pone.0043638.g003
Figure 4. The effect of R. conorii on b-catenin activation in HUVECs. The figure shows the effect of heat-inactivated R. conorii (400,000/ml) in
HUVECs on the accumulation of total (phosphorylated and non-phosphorylated) b-catenin in cytosol (A) and within the nucleus (B) after culturing for
15 minutes (min) and 2 hours (h). Data are given as mean6SEM (n = 6). ***P,.001 vs. un-stimulated cells (US) at the same time point.
doi:10.1371/journal.pone.0043638.g004
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Effect of silencing DKK-1 on the heat-inactivated R.
conorii-mediated induction of pro- and anti-thrombotic
mediators in endothelial cells
In addition to vasculitis, thrombus formation related to
endothelial cell activation is an important clinical manifestation
of SFG rickettsioses [4,19]. We therefore next examined the effect
of silencing DKK-1 on the R. conorii-induced expression of
endothelial-derived pro- (i.e., TF and PAI-1) and anti- (i.e.,
thrombomodulin) thrombotic mediators. While heat-inactivated
R. conorii enhanced the expression of TF in scrambled control cells,
silencing DKK-1 attenuated mRNA levels of TF after culturing
for 6 hours in both un-stimulated and R. conorii-exposed cells
Figure 5. The effect of silencing DKK-1 on the R. conorii-induced cytokine levels in HUVECs. The figure shows the effect of different
concentrations of R. conorii in HUVECs on mRNA expression (left panel) and release of protein in cell supernatants (right panel) of DKK-1 (A), IL-6 (B),
IL-8 (C) and GROa (D) in the presence (siDKK, filled bars) and absence (siSCR, open bars) of siRNA probes to silence DKK-1. Silencing for 24 hours plus
culturing for 6 (mRNA) and 24 (protein) hours respectively. Data are given as mean6SEM (n = 4). **P,.01, ***P,.001 vs. siSCR treated cells (control
cells). {P,.05, {{P,.01 and {{{P,.001 vs. un-stimulated (US) siSCR treated cells.
doi:10.1371/journal.pone.0043638.g005
DKK-1 in Rickettsia conorii Infection
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(Figure 6). In contrast, whereas R. conorii decreased the expression
of thrombomodulin in control cells, silencing DKK-1 enhanced
mRNA levels of this anti-thrombotic mediator in both un-
stimulated and R. conorii-stimulated cells suggesting anti-throm-
botic net effects of silencing DKK-1 in endothelial cells (Figure 6).
In fact, silencing of DKK-1 resulted in a significant decrease in
TF in R. conorii-exposed cells even compared with un-stimulated
non-silenced cells (Figure 6). As for PAI-1 mRNA levels, there
were no significant differences between silenced and non-silenced
HUVECs in either un-stimulated or R. conorii-exposed cells
(Fig. 6).
Recombinant DKK-1 attenuates, but does not abolish,
the suppressive effect of silencing DKK-1 on IL-6 release
in HUVECs
To further explore the role of DKK-1 in endothelial-related
inflammation, we examined if recombinant DKK-1 could
counteract the down-regulatory effect of silencing DKK-1 on
IL-6 release. As shown in Figure 7, when adding recombinant
DKK-1 to HUVECs that had silenced DKK-1, there was a dose-
dependent increase in IL-6 release reaching statistical significance
at a concentration of 1 mg/ml. However, although significant, the
increase was rather modest (20%), and the addition of recom-
binant DKK-1 did not reverse the inhibitory effect of siDKK-1
on IL-6 release. This may suggest that it is the intracellular and
not the secreted form of DKK-1 that is of most importance for
the effect of DKK-1 on inflammatory mediators in endothelial
cells.
Discussion
The infection of endothelial cells and subsequent perivascular
infiltration of leukocyte subpopulations is a major feature of
infection with R. conorii and other SFG rickettsioses [2,4]. This
inflammatory interaction between R. conorii and endothelial cells
involves the release of inflammatory cytokines and chemokines as
well as up-regulation of adhesion molecules on endothelial cells
and leukocytes [2,4,14]. The inflammatory response within the
Figure 6. The effect of silencing DKK-1 on the R. conorii-induced levels of pro- and anti-thrombotic mediators in HUVECs. The figure
shows the effect of different concentrations of R. conorii in HUVEC on mRNA expression of tissue factor (TF), plasminogen activator inhibitor (PAI-1)
and thrombomodulin (TM) in the presence (siDKK, filled bars) and absence (siSCR, open bars) of siRNA probes to silence DKK-1 after silencing for
24 hours with additional culturing for 6 hours. Data are given as mean6SEM (n = 4). *P,.05, ***P,.001 vs. siSCR treated cells (control cells). {P,.05
and {{P,.01 vs. un-stimulated (US) siSCR treated cells.
doi:10.1371/journal.pone.0043638.g006
Figure 7. The effect of different concentrations of recombinant
DKK-1 (mg/ml) on the release of IL-6 in HUVECs in the presence
of siRNA probes to silence DKK-1 (culture time 24 hours). Data
are given as mean6SEM (n = 4). *P,.05 vs. un-stimulated cells (US).
doi:10.1371/journal.pone.0043638.g007
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endothelium may be of importance for clearance of the bacteriae,
whereas an overwhelming and persistent inflammatory response
could also contribute to tissue damage and disease progression. In
the present study we report for the first time an interaction
between R. conorii and the Wnt pathway in the endothelium, with a
decreased release of endothelial-derived DKK-1 in R. conorii
exposed cells. Based on our finding in siDKK-1 transfected cells,
with markedly attenuated inflammatory responses in cells with
decreased DKK-1 expression, it is tempting to hypothesize that
the R. conorii-induced down-regulation of endothelial-derived
DKK-1 may reflect an immune evasion mechanism that facilitates
rickettsial infection in the vascular bed.
Activation of the Wnt signaling pathway has been suggested to
promote inflammation [7–10,12], but there are also some reports
indicating that this pathway could be involved in anti-inflamma-
tory responses. Hence, recent studies suggest that DKK-1, an
inhibitor of the Wnt signaling pathway, possess inflammatory
properties. DKK-1 has been shown to trigger inflammation-
induced bone loss [6,21]. In endothelial cells, DKK-1 has been
found to promote angiogenesis and enhance the inflammatory
interaction between platelets and endothelial cells [11,22]. In the
present study we extend these findings by showing that silencing
DKK-1 markedly attenuated the inflammatory response to heat-
inactivated R. conorii in HUVECs with down-regulatory effects on
IL-6, GROa and IL-8 at both mRNA and protein level.
Moreover, we show that the effect of silencing DKK-1 in
HUVECs is not restricted to inflammation. Down-regulation of
DKK-1 in R. conorii-exposed HUVECs attenuated TF expression
and enhanced thrombomodulin expression, suggesting pro-
thrombotic net effect of DKK-1. Our findings further support a
role for DKK-1 in vascular inflammation and atherothrombosis,
and neutralization of DKK-1 could potentially represent a
therapeutic target in relevant disorders.
Inflammatory stimuli such as TNFa have been shown to induce
enhanced DKK-1 release in various cells [6]. Patients with MSF
have previously been reported to have an early rise in TNFa and
other inflammatory mediators [23]. It is therefore noteworthy that
we found that patients with R. conorii infection had DKK-1 levels
within the range of healthy controls when attending the hospital
and before any specific treatment. However, endothelial cells
release large amounts of DKK-1 upon activation, and the capacity
of R. conorii to down-regulate DKK-1 in these cells, as opposed to
its enhancing effect on IL-6 and IL-8, as shown in the present
study, could counteract the increase in DKK-1 in relation to
inflammatory stimuli in MSF patients. Yet, although heat-
inactivated R. conorii down-regulated the release of DKK-1 from
endothelial cells, there was no initial decrease in DKK-1 levels in
serum in patients with R. conorii infection. This could potentially
reflect contribution of other cells than endothelial cells to DKK-1
levels in serum. In fact, while R. conorii decreased the release of
DKK-1 in HUVECs, it enhanced the release of DKK-1 in
platelets and whole blood culture. In contrast to serum levels of
DKK-1 at baseline, there was a significant increase in DKK-1
levels after 7 days. The reason for this pattern is at present unclear.
Based on the ability of R. conorii to attenuate DKK-1 release, the
possible clearance of R. conorii at time point 2 could contribute to a
late increase in DKK-1. Second, the late increase could also be
secondary to effects of inflammatory cytokines released during R.
conorii infection known to induce DKK-1 release (e.g. TNFa).
Nonetheless, our findings suggest that R. conorii affects DKK-1 and
inflammatory cytokines differently both in vivo and in vitro in
endothelial cells.
Immune evasion is of importance for the survival of microbes
within the host, and such mechanisms also seem to be related to
Rickettsial infection involving selection of inteferon-c resistant
strains, evasion of phagosomes and induction of anti-apoptotic
mechanisms in endothelial cells [2,4]. The production of
inflammatory cytokines such as IL-6, IL-8, IL-12 and chemokines
is crucial in the innate and adaptive immune responses to
infections, and some bacterial pathogens have evolved mecha-
nisms for attenuating cytokine production by host cells, which
modifies the host’s subsequent immune response [3]. Our findings
in the present study could suggest that such mechanisms might be
involved in immune evasion of R. conorii through its ability to
down-regulate DKK-1 in endothelial cells. The Wnt signaling
pathway has been linked to immune evasion mechanisms in
relation to malignancies [24], and interestingly, recent studies
indicate that Wnt signaling could be implicated in immune evasion
in Mycobacteria and salmonella infection through anti-inflamma-
tory and anti-apoptotic mechanisms, respectively. [25,26] Our
findings herein may suggest that the Wnt signaling pathway could
also be involved in R. conorii related immune evasion by its ability
to down-regulate DKK-1 expression in endothelial cells. The anti-
apoptotic effects of DKK-1 may further support such a notion.
[27,28]. The current study has some limitations such as the use of
heat-inactivated as opposed to live bacteria and a relative low
number of patients with MSF. However, although our data are
preliminary, we suggest that the capacity of R. conorii to down-
regulate endothelial-derived DKK-1 as well as the ability of
silencing DKK-1 to attenuate R. conorii-induced inflammatory
responses in endothelial cells could reflect a novel mechanism by
which R. conorii escapes the immune response at the site of
infection. Yet, further studies are needed to establish this
hypothesis as an important mechanism in SFG rickettsioses. Such
studies should comprise more mechanistic studies including
intervention studies in mice models for R. conorii infection.
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